144 related articles for article (PubMed ID: 1507211)
1. Conformationally restrained, chiral (phenylisopropyl)amino-substituted pyrazolo[3,4-d]pyrimidines and purines with selectivity for adenosine A1 and A2 receptors.
Peet NP; Lentz NL; Sunder S; Dudley MW; Ogden AM
J Med Chem; 1992 Aug; 35(17):3263-9. PubMed ID: 1507211
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 1H-pyrazolo[4,3-d]pyrimidine-7(6H)-ones and pyrazolo-5-carboxamides and interaction with benzodiazepine and adenosine A1 receptors in rat cerebral cortex.
Baraldi PG; Casolari A; Manfredini S; Periotto V; Zanirato V; Florio C; Traversa V; Bertelli GM; Borea PA
Arzneimittelforschung; 1988 Sep; 38(9):1262-5. PubMed ID: 2852012
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and adenosine receptor affinity of a series of pyrazolo[3,4-d]pyrimidine analogues of 1-methylisoguanosine.
Harden FA; Quinn RJ; Scammells PJ
J Med Chem; 1991 Sep; 34(9):2892-8. PubMed ID: 1895306
[TBL] [Abstract][Full Text] [Related]
5. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
Müller CE; Geis U; Grahner B; Lanzner W; Eger K
J Med Chem; 1996 Jun; 39(13):2482-91. PubMed ID: 8691445
[TBL] [Abstract][Full Text] [Related]
6. High-pressure synthesis of enantiomerically pure C-6 substituted pyrazol.
Poulsen SA; Young DJ; Quinn RJ
Bioorg Med Chem Lett; 2001 Jan; 11(2):191-3. PubMed ID: 11206456
[TBL] [Abstract][Full Text] [Related]
7. 1H-pyrazolo[4,3-d]pyrimidine-7(6H)-one and 5H-pyrazolo[4,3-d] 1,2,3-triazin-4(3H)-one derivatives. Synthesis and in vitro biological activity at adenosine A1 and A2a receptors.
Baraldi PG; Cacciari B; Dalpiaz A; Dionisotti S; Zocchi C; Pineda de las Infantas MJ; Spalluto G; Varani K
Arzneimittelforschung; 1996 Apr; 46(4):365-8. PubMed ID: 8740079
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of pyrazolo[4,3-d]pyrimidin-7-ones as adenosine receptor antagonists.
Hamilton HW; Ortwine DF; Worth DF; Bristol JA
J Med Chem; 1987 Jan; 30(1):91-6. PubMed ID: 3806606
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists.
Poulsen SA; Quinn RJ
J Med Chem; 1996 Oct; 39(21):4156-61. PubMed ID: 8863792
[TBL] [Abstract][Full Text] [Related]
10. Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpurines.
Gillespie RJ; Cliffe IA; Dawson CE; Dourish CT; Gaur S; Jordan AM; Knight AR; Lerpiniere J; Misra A; Pratt RM; Roffey J; Stratton GC; Upton R; Weiss SM; Williamson DS
Bioorg Med Chem Lett; 2008 May; 18(9):2924-9. PubMed ID: 18411049
[TBL] [Abstract][Full Text] [Related]
11. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists.
Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Klotz KN; Leung E; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 1999 Nov; 42(22):4473-8. PubMed ID: 10579811
[No Abstract] [Full Text] [Related]
12. Synthesis and biological activity of 8-azapurine and pyrazolo[4,3-d]pyrimidine analogues of myoseverin.
Krystof V; Moravcová D; Paprskárová M; Barbier P; Peyrot V; Hlobilková A; Havlícek L; Strnad M
Eur J Med Chem; 2006 Dec; 41(12):1405-11. PubMed ID: 16996651
[TBL] [Abstract][Full Text] [Related]
13. 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A₁ and A(2A) adenosine receptors. Molecular modeling and pharmacological studies.
Squarcialupi L; Colotta V; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Borea PA; Porta N; Ciancetta A; Moro S
Eur J Med Chem; 2014 Sep; 84():614-27. PubMed ID: 25063944
[TBL] [Abstract][Full Text] [Related]
14. 7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists.
Müller CE; Hide I; Daly JW; Rothenhäusler K; Eger K
J Med Chem; 1990 Oct; 33(10):2822-8. PubMed ID: 2213835
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists.
Baraldi PG; Cacciari B; Spalluto G; Bergonzoni M; Dionisotti S; Ongini E; Varani K; Borea PA
J Med Chem; 1998 Jun; 41(12):2126-33. PubMed ID: 9622554
[TBL] [Abstract][Full Text] [Related]
16. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
[TBL] [Abstract][Full Text] [Related]
17. A facile and novel synthesis of N(2)-, C(6)-substituted pyrazolo[3,4-d]pyrimidine-4 carboxylate derivatives as adenosine receptor antagonists.
Venkatesan G; Paira P; Cheong SL; Federico S; Klotz KN; Spalluto G; Pastorin G
Eur J Med Chem; 2015 Mar; 92():784-98. PubMed ID: 25633494
[TBL] [Abstract][Full Text] [Related]
18. The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA(3) adenosine receptors antagonists: new insights into structure-affinity relationship and receptor-antagonist recognition.
Cheong SL; Dolzhenko A; Kachler S; Paoletta S; Federico S; Cacciari B; Dolzhenko A; Klotz KN; Moro S; Spalluto G; Pastorin G
J Med Chem; 2010 Apr; 53(8):3361-75. PubMed ID: 20307065
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of some novel pyrazolopyrimidines incorporating a benzothiazole ring system.
Azam MA; Dharanya L; Mehta CC; Sachdeva S
Acta Pharm; 2013 Mar; 63(1):19-30. PubMed ID: 23482310
[TBL] [Abstract][Full Text] [Related]
20. Novel 3-aralkyl-7-(amino-substituted)-1,2,3-triazolo[4,5-d]pyrimidines with high affinity toward A1 adenosine receptors.
Betti L; Biagi G; Giannaccini G; Giorgi I; Livi O; Lucacchini A; Manera C; Scartoni V
J Med Chem; 1998 Feb; 41(5):668-73. PubMed ID: 9513594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
